- Home
- FLNC vs SLNO Comparison
FLNC vs SLNO Comparison
Compare FLNC & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLNC | SLNO |
|---|---|---|
| Founded | 2018 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.3B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FLNC | SLNO |
|---|---|---|
| Price | $14.97 | $31.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 18 | 11 |
| Target Price | $16.93 | ★ $105.27 |
| AVG Volume (30 Days) | ★ 3.6M | 1.5M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 108.90 |
| EPS | N/A | ★ 0.39 |
| Revenue | ★ $2,262,830,000.00 | $1,450,788.00 |
| Revenue This Year | $51.18 | $150.65 |
| Revenue Next Year | $21.37 | $56.10 |
| P/E Ratio | ★ N/A | $81.64 |
| Revenue Growth | N/A | ★ 138.82 |
| 52 Week Low | $3.46 | $30.11 |
| 52 Week High | $33.51 | $89.12 |
Technical Indicators
Market Signals| Indicator | FLNC | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 39.11 | 31.22 |
| Support Level | $13.92 | N/A |
| Resistance Level | $18.21 | $41.48 |
| Average True Range (ATR) | 0.95 | 1.75 |
| MACD | 0.19 | -0.34 |
| Stochastic Oscillator | 2.43 | 12.56 |
Price Performance
Historical ComparisonAbout FLNC Fluence Energy Inc.
Fluence Energy Inc provides intelligent energy storage and optimization software for renewables and storage. Its energy storage solutions and operational services support a more resilient grid and help unlock the potential of renewable portfolios. The company's offerings include energy storage solutions, recurring operational and maintenance services, and Software-as-a-Service (SaaS) products designed to meet customer business needs, performance requirements, in-house capabilities, and risk profiles. Its service plans offer varying levels of training, maintenance, guarantees, warranties, and support for active system management. The company operates in the Americas, APAC and EMEA, with the majority of revenue coming from the Americas.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.